Can Betatrophin Predict the Risk of Preeclampsia?

Introduction: Preeclampsia, a hypertensive disease of pregnancy, is globally one of the primary causes of maternal morbidity and mortality. Betatrophin is shown to be a novel adipokine in pathophysiology of metabolic disorders. It plays a role in glucose and lipid metabolism and is associated with d...

Full description

Bibliographic Details
Main Authors: Engin Ersin Simsek, Halim Omer Kasikci, Onder Sakin, Semih Korkut
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2018-10-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/12149/36991_CE[Ra1]_F(SL)_PF1(SJ_SHU)_PN(P).pdf
_version_ 1818610786788966400
author Engin Ersin Simsek
Halim Omer Kasikci
Onder Sakin
Semih Korkut
author_facet Engin Ersin Simsek
Halim Omer Kasikci
Onder Sakin
Semih Korkut
author_sort Engin Ersin Simsek
collection DOAJ
description Introduction: Preeclampsia, a hypertensive disease of pregnancy, is globally one of the primary causes of maternal morbidity and mortality. Betatrophin is shown to be a novel adipokine in pathophysiology of metabolic disorders. It plays a role in glucose and lipid metabolism and is associated with diabetes mellitus, obesity and metabolic syndrome. Aim: To analyse the relationship between betatrophin levels and the occurrence/severity of preeclampsia. Materials and Methods: A prospective cross-sectional study was carried out for a sample of 73 women diagnosed with preeclampsia (severe and mild) and 76 healthy pregnant controls matched for betatrophin levels, age, Body Mass Index (BMI), and gestational age. All data were analysed using the Statistical Package for the Social Sciences (SPSS) version 17 program (SPSS Inc., Chicago, IL, USA). Distribution of data was evaluated with Kolmogorov–Smirnov test. Results were presented as medians (interquartile range) except for normal parameters that are presented as mean±SD. The data with normal distribution were analysed with one-way ANOVA test whereas data without normal distribution were evaluated with Kruskal-Wallis test. Correlations between betatrophin and biochemical markers were assessed using Spearman’s correlation test. Results were evaluated with 95% confidence intervals and the level of significance was indicated as p<0.05. Results: Betatrophin levels (in ng/mL) were 2.2±0.6 in severe preeclampsia group, 2.0±0.5 in mild preeclampsia group, and 1.3±0.6 in control group. There were significant differences between severe preeclampsia and control groups (p<0.001) and also between mild preeclampsia and control groups (p<0.001). On the other hand, no significant difference was found between severe and mild preeclampsia groups. Furthermore, betatrophin concentrations were found to be significantly positively correlated with both diastolic blood pressure and Homeostasis Model Assessment of Insulin Resistance Index (HOMA-IR) (p<0.001). This is also shown to be associated with the presence of preeclampsia. Conclusion: Betatrophin is believed to be an important predictive biomarker that can be studied for early diagnosis and management of preeclampsia in pregnancies with high risk. More specifically, studies that focus on the evolution of this relationship over the pregnancy weeks could help reduce the maternal and fetal death rates in developing countries. Further randomized trials are needed in order to determine the applicability of this approach in clinical practice.
first_indexed 2024-12-16T15:19:58Z
format Article
id doaj.art-f1e2ae07cdd74fa884a3779d64b07f9c
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-12-16T15:19:58Z
publishDate 2018-10-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-f1e2ae07cdd74fa884a3779d64b07f9c2022-12-21T22:26:41ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2018-10-011210QC12QC1510.7860/JCDR/2018/36991.12149Can Betatrophin Predict the Risk of Preeclampsia?Engin Ersin Simsek0Halim Omer Kasikci1Onder Sakin2Semih Korkut3Department of Family Medicine, University of Health Sciences, Dr.Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Kartal, Turkey.Department of Family Medicine, University of Health Sciences, Dr.Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Kartal, Turkey.Department of Obstetrics and Gynecology, University of Health Sciences, Dr.Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Kartal, Turkey.Department of Emergency Medicine, University of Health Sciences, Dr. Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Kartal, Turkey.Introduction: Preeclampsia, a hypertensive disease of pregnancy, is globally one of the primary causes of maternal morbidity and mortality. Betatrophin is shown to be a novel adipokine in pathophysiology of metabolic disorders. It plays a role in glucose and lipid metabolism and is associated with diabetes mellitus, obesity and metabolic syndrome. Aim: To analyse the relationship between betatrophin levels and the occurrence/severity of preeclampsia. Materials and Methods: A prospective cross-sectional study was carried out for a sample of 73 women diagnosed with preeclampsia (severe and mild) and 76 healthy pregnant controls matched for betatrophin levels, age, Body Mass Index (BMI), and gestational age. All data were analysed using the Statistical Package for the Social Sciences (SPSS) version 17 program (SPSS Inc., Chicago, IL, USA). Distribution of data was evaluated with Kolmogorov–Smirnov test. Results were presented as medians (interquartile range) except for normal parameters that are presented as mean±SD. The data with normal distribution were analysed with one-way ANOVA test whereas data without normal distribution were evaluated with Kruskal-Wallis test. Correlations between betatrophin and biochemical markers were assessed using Spearman’s correlation test. Results were evaluated with 95% confidence intervals and the level of significance was indicated as p<0.05. Results: Betatrophin levels (in ng/mL) were 2.2±0.6 in severe preeclampsia group, 2.0±0.5 in mild preeclampsia group, and 1.3±0.6 in control group. There were significant differences between severe preeclampsia and control groups (p<0.001) and also between mild preeclampsia and control groups (p<0.001). On the other hand, no significant difference was found between severe and mild preeclampsia groups. Furthermore, betatrophin concentrations were found to be significantly positively correlated with both diastolic blood pressure and Homeostasis Model Assessment of Insulin Resistance Index (HOMA-IR) (p<0.001). This is also shown to be associated with the presence of preeclampsia. Conclusion: Betatrophin is believed to be an important predictive biomarker that can be studied for early diagnosis and management of preeclampsia in pregnancies with high risk. More specifically, studies that focus on the evolution of this relationship over the pregnancy weeks could help reduce the maternal and fetal death rates in developing countries. Further randomized trials are needed in order to determine the applicability of this approach in clinical practice.https://jcdr.net/articles/PDF/12149/36991_CE[Ra1]_F(SL)_PF1(SJ_SHU)_PN(P).pdfbetatrophinmild preeclampsiasevere preeclampsia
spellingShingle Engin Ersin Simsek
Halim Omer Kasikci
Onder Sakin
Semih Korkut
Can Betatrophin Predict the Risk of Preeclampsia?
Journal of Clinical and Diagnostic Research
betatrophin
mild preeclampsia
severe preeclampsia
title Can Betatrophin Predict the Risk of Preeclampsia?
title_full Can Betatrophin Predict the Risk of Preeclampsia?
title_fullStr Can Betatrophin Predict the Risk of Preeclampsia?
title_full_unstemmed Can Betatrophin Predict the Risk of Preeclampsia?
title_short Can Betatrophin Predict the Risk of Preeclampsia?
title_sort can betatrophin predict the risk of preeclampsia
topic betatrophin
mild preeclampsia
severe preeclampsia
url https://jcdr.net/articles/PDF/12149/36991_CE[Ra1]_F(SL)_PF1(SJ_SHU)_PN(P).pdf
work_keys_str_mv AT enginersinsimsek canbetatrophinpredicttheriskofpreeclampsia
AT halimomerkasikci canbetatrophinpredicttheriskofpreeclampsia
AT ondersakin canbetatrophinpredicttheriskofpreeclampsia
AT semihkorkut canbetatrophinpredicttheriskofpreeclampsia